Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by ^[18F]FDG-PET/CT

Author： Kauppi Juha T. Oksala Niku Salo Jarmo A. Helin Heikki Karhumäki Lauri Kemppainen Jukka Sihvo Eero I. Räsänen Jari V.

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.51, Iss.5, 2012-05, pp. : 636-644

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Determinants of Response to Neoadjuvant Chemotherapy for Esophageal Cancer Using ¹⁸F-fluorodeoxiglucose Positron Emission Tomography (¹⁸F-FDG-PET)

By Miyata Hiroshi Yamasaki Makoto Takahashi Tsuyoshi Murakami Kohei Tanaka Koji Yukinori Kurokawa Nakajima Kiyokazu Takiguchi Shuji Morii Eiichi Hatazawa Jun Mori Masaki Doki Yuichiro

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 575-582

Springer Publishing Company

Access to resources Recommend Favorite

Early Assessment of Axillary Response with ¹⁸F-FDG PET/CT during Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla

By Koolen Bas Valdés Olmos Renato Wesseling Jelle Vogel Wouter Vincent Andrew Gilhuijs Kenneth Rodenhuis Sjoerd Rutgers Emiel Vrancken Peeters Marie-Jeanne

Annals of Surgical Oncology, Vol. 20, Iss. 7, 2013-07 ,pp. : 2227-2235

Springer Publishing Company

Access to resources Recommend Favorite

Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma

By Kikuchi Masahiro

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 402-410

Springer Publishing Company

Access to resources Recommend Favorite

Reply to “Anti-cytokeratin CAM5.2 Recognized CK8 Mainly, but not CK18: Comment on ‘Early Assessment of Axillary Response with ¹⁸F-FDG PET/CT During Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla. Ann Surg Oncol. 2013;20(7):2227–35’”

By Koolen Bas Wesseling Jelle

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 700-700

Springer Publishing Company

Access to resources Recommend Favorite

Anti-cytokeratin CAM5.2 Recognized CK8 Mainly, but not CK18: Comment on “Early Assessment of Axillary Response with ¹⁸F-FDG PET/CT During Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla. Annals of Surgical Oncology doi: 10.1245/s10434-013-2902-0 (2013)”

By Chao Wan-Ru Han Chih-Ping

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 699-699

Springer Publishing Company

Access to resources Recommend Favorite